Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech SA    STDM   FR0000053266

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 201320142015201620172018
Sales5886848841 0111 1031 228
Operating income (EBITDA)136161231277307344
Operating profit (EBIT)-120-230258295
Pre-Tax Profit (EBT)-105170216247278
Net income67,572,5139152175200
P/E ratio24,934,239,020,818,110,8
EPS ( € )0,820,791,512,973,425,72
Dividend per Share ( € )0,200,22-0,350,400,48
Yield0,98%0,81%-0,56%0,64%0,78%
Reference price ( € )20.308326.883358.961.961.961.9
Announcement Date01/28/2014
06:00am
01/27/2015
04:00pm
02/01/2016
06:00am
---
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 201320142015201620172018
Debt-87,486,4---
Finance---14,059,1224
Operating income (EBITDA)136161231277307344
Leverage
(Debt/EBITDA)
-0,54x0,37x---
Capital Expenditure29,347,153,069,776,271,0
Book Value Per Share (BVPS)-5,78 €6,96 €6,94 €6,64 €8,71 €
Cash Flow per Share-1,21 €-1,62 €1,84 €1,50 €
Announcement Date01/28/2014
06:00am
01/27/2015
04:00pm
02/01/2016
06:00am
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 5 706 M€ -
Entreprise Value (EV) 5 692 M€ 5 647 M€
Valuation 2016e 2017e
P/E ratio (Price / EPS) 20,8x 18,1x
Capitalization / Revenue 5,64x 5,17x
EV / Revenue 5,63x 5,12x
EV / EBITDA 20,5x 18,4x
Yield (DPS / Price) 0,56% 0,64%
Price to book (Price / BVPS) 8,91x 9,33x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 22,7% 23,4%
operating Leverage (Delta EBIT / Delta Sales) - 1,35x
Net Margin (Net Profit / Revenue) 15,1% 15,8%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 20,7% 20,3%
Rate of Dividend 11,7% 11,7%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   6,89% 6,91%
Cash Flow / Sales 14,8% 15,4%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) -0,05x -0,19x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend